Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Feb;68(2):243-53.
doi: 10.1016/j.joms.2009.03.050. Epub 2009 Sep 24.

Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure

Collaborators, Affiliations

Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure

Joan C Lo et al. J Oral Maxillofac Surg. 2010 Feb.

Abstract

Purpose: Osteonecrosis of the jaw (ONJ) is a serious complication associated with bisphosphonate therapy, but its epidemiology in the setting of oral bisphosphonate therapy is poorly understood. The present study examined the prevalence of ONJ in patients receiving chronic oral bisphosphonate therapy.

Materials and methods: We mailed a survey to 13,946 members who had received chronic oral bisphosphonate therapy as of 2006 within a large integrated health care delivery system in Northern California. Respondents who reported ONJ, exposed bone or gingival sores, moderate periodontal disease, persistent symptoms, or complications after dental procedures were invited for examination or to have their dental records reviewed. ONJ was defined as exposed bone (of >8 weeks' duration) in the maxillofacial region in the absence of previous radiotherapy.

Results: Of the 8,572 survey respondents (71 +/- 9 years, 93% women), 2,159 (25%) reported pertinent dental symptoms. Of these 2,159 patients, 1,005 were examined and an additional 536 provided dental records. Nine ONJ cases were identified, representing a prevalence of 0.10% (95% confidence interval 0.05% to 0.20%) among the survey respondents. Of the 9 cases, 5 had occurred spontaneously (3 in palatal tori) and 4 occurred in previous extraction sites. An additional 3 patients had mandibular osteomyelitis (2 after extraction and 1 with implant failure) but without exposed bone. Finally, 7 other patients had bone exposure that did not fulfill the criteria for ONJ.

Conclusions: ONJ occurred in 1 of 952 survey respondents with oral bisphosphonate exposure (minimum prevalence of 1 in 1,537 of the entire mailed cohort). A similar number had select features concerning for ONJ that did not meet the criteria. The results of the present study provide important data on the spectrum of jaw complications among patients with oral bisphosphonate exposure.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Recruitment and Examination of the PROBE Study Cohort
Figure 2.
Figure 2.. Radiographic Findings in Osteonecrosis of the Jaw after Dental Extraction
Case 7: Axial CT showing an irregular area of bony sclerosis (12.5 mm x 9.3 mm) corresponding to the extraction site (maxillary molar extraction occurred 11 months prior to scan date). Case 9a: Axial CT showing sclerosis with areas of lucency proximal to the extraction site (mandibular bicuspid extraction occurred 14 months prior to scan date). The lamina dura is thickened and sclerotic, and the extraction socket is still visible radiographically.
Figure 2.
Figure 2.. Radiographic Findings in Osteonecrosis of the Jaw after Dental Extraction
Case 7: Axial CT showing an irregular area of bony sclerosis (12.5 mm x 9.3 mm) corresponding to the extraction site (maxillary molar extraction occurred 11 months prior to scan date). Case 9a: Axial CT showing sclerosis with areas of lucency proximal to the extraction site (mandibular bicuspid extraction occurred 14 months prior to scan date). The lamina dura is thickened and sclerotic, and the extraction socket is still visible radiographically.
Figure 3.
Figure 3.. Radiographic Findings in Osteonecrosis of the Jaw-like (ONJ-like) Cases
Case 12: Cone beam CT demonstrating severe osteolysis around 3 of 4 implants with sclerosis of the remaining bone to the inferior border of the mandible. Case 16: Axial CT showing osteosclerosis surrounding an area of lucency corresponding to the extraction site (mandibular molar extraction occurred 4 months prior to scan date). Case 18: Panoramic radiograph demonstrating a focal osteolytic defect with sclerosis of the surrounding bone and increased density of the left inferior alveolar canal. The patient reported a distant extraction history (>10 years ago) with recurrent bony spicules and spontaneous tooth loss in this region over the past year.
Figure 3.
Figure 3.. Radiographic Findings in Osteonecrosis of the Jaw-like (ONJ-like) Cases
Case 12: Cone beam CT demonstrating severe osteolysis around 3 of 4 implants with sclerosis of the remaining bone to the inferior border of the mandible. Case 16: Axial CT showing osteosclerosis surrounding an area of lucency corresponding to the extraction site (mandibular molar extraction occurred 4 months prior to scan date). Case 18: Panoramic radiograph demonstrating a focal osteolytic defect with sclerosis of the surrounding bone and increased density of the left inferior alveolar canal. The patient reported a distant extraction history (>10 years ago) with recurrent bony spicules and spontaneous tooth loss in this region over the past year.
Figure 3.
Figure 3.. Radiographic Findings in Osteonecrosis of the Jaw-like (ONJ-like) Cases
Case 12: Cone beam CT demonstrating severe osteolysis around 3 of 4 implants with sclerosis of the remaining bone to the inferior border of the mandible. Case 16: Axial CT showing osteosclerosis surrounding an area of lucency corresponding to the extraction site (mandibular molar extraction occurred 4 months prior to scan date). Case 18: Panoramic radiograph demonstrating a focal osteolytic defect with sclerosis of the surrounding bone and increased density of the left inferior alveolar canal. The patient reported a distant extraction history (>10 years ago) with recurrent bony spicules and spontaneous tooth loss in this region over the past year.
Figure 4.
Figure 4.. The Prevalence of Osteonecrosis of the Jaw (ONJ) by Duration of Bisphosphonate (BP) Therapy
Error bars represent the 95% confidence interval.

References

    1. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg. Mar 2007;65(3):369–376. - PubMed
    1. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. Sep 2003;61(9):1115–1117. - PubMed
    1. Migliorati CA. Bisphosphanates and oral cavity avascular bone necrosis. J Clin Oncol. Nov 15 2003;21(22):4253–4254. - PubMed
    1. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg. Nov 2005;63(11):1567–1575. - PubMed
    1. Ruggiero SL, Mehrotra B, Rosenberg TJ, Engroff SL. Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg. May 2004;62(5):527–534. - PubMed

Publication types

MeSH terms